Ultragenyx Pharmaceutical Inc. buy JPMorgan Chase & Co.
Start price
27.02.24
/
50%
€49.60
Target price
27.02.25
€81.12
Performance (%)
7.86%
Price
17.09.24
€52.00
Summary
This prediction is currently active. The BUY prediction by JPMorgan_Chase___Co_ shows slight gains of 7.86%. This prediction currently runs until 27.02.25. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Ultragenyx Pharmaceutical Inc. | 4.950% | 4.950% |
iShares Core DAX® | 1.887% | 1.967% |
iShares Nasdaq 100 | 2.316% | -1.227% |
iShares Nikkei 225® | 1.134% | 0.390% |
iShares S&P 500 | 1.821% | 0.790% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Ultragenyx Pharmaceutical Inc. diskutieren
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) had its price target raised by analysts at JPMorgan Chase & Co. from $84.00 to $88.00. They now have an "overweight" rating on the stock.
Ratings data for RARE provided by MarketBeat